SCHEMBL6716385

SCHEMBL6716385

CCOC(=O)C(Cc1ccc(OCCNC(=O)c2ccc(-c3ccccn3)cc2)c([N+](=O)[O-])c1)Oc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARG P37231 6/20 0.49
MAPT P10636 3/20 0.42
LMNA P02545 6/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
ALDH1A1 P00352 4/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
RAB9A P51151 3/20 0.41
HTT P42858 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
POLB P06746 2/20 0.41
NPC1 O15118 1/20 0.40
TGFBR1 P36897 1/20 0.40
CTDSP1 Q9GZU7 1/20 0.40
F2 P00734 1/20 0.39
F10 P00742 1/20 0.39
PRSS1 P07477 1/20 0.39
GAA P10253 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6717894 0.92 PPARG (0.50) PPARGMAPTLMNASMN1; SMN2ALDH1A1
SCHEMBL6716578 0.88 PPARG (0.51) PPARGSMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL6713627 0.88 PPARG (0.51) PPARGMAPTLMNASMN1; SMN2ALDH1A1
SCHEMBL6717755 0.85 NPC1 (0.48) PPARGMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL6712846 0.84 PPARG (0.47) PPARGMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL6715973 0.81 NPC1 (0.51) PPARGMAPTLMNASMN1; SMN2MEN1
SCHEMBL6714895 0.81 NPC1 (0.49) PPARGMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL6716355 0.80 ALDH1A1 (0.42) MAPTALDH1A1HTTPOLBL3MBTL1
SCHEMBL6716164 0.80 PPARG (0.45) PPARGMAPTLMNASMN1; SMN2ALDH1A1
SCHEMBL6718245 0.80 NPC1 (0.50) PPARGMAPTSMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 PPARG 23/4885MAPT 4838/4885LMNA 4239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.